Regorafenib for the treatment of unresectable hepatocellular carcinoma
2017-01-01 Rimassa, L; Pressiani, T; Personeni, N; Santoro, A
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016-01-01 Personeni, N.; Baretti, M.; Bozzarelli, S.; Spaggiari, P.; Rubino, L.; Tronconi, M. C.; Fumagalli Romario, U.; Rosati, R.; Giordano, L.; Roncalli, M.; Santoro, A.; Rimassa, L.
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study
2015-01-01 Personeni, N.; Rimassa, L.; Verusio, C.; Barni, S.; Rubino, L.; Bozzarelli, S.; Villa, E.; Carnaghi, C.; Tronconi, M. C.; Gerardi, C.; Galli, F.; Floriani, I.; Destro, A.; Raschioni, C.; Labianca, R.; Santoro, A.
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity?
2018-01-01 Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer
2007-01-01 M, Colozza; E, Azambuja; Personeni, N.; F, Lebrun; Mj, Piccart; F., Cardoso
OncoAlert round table discussions: The global COVID-19 experience
2021-01-01 Morgan, G; De Azambuja, E; Punie, K; Ades, F; Heinrich, K; Personeni, N; Rahme, R; Ferrara, R; Pels, K; Garassino, M; von Bergwelt-Baildon, M; Lopes, G; Barlesi, F; Choueiri, Tk; Burris, H; Peters, S
Regorafenib for the treatment of unresectable hepatocellular carcinoma
2017-01-01 Rimassa, L; Pressiani, T; Personeni, N; Santoro, A
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013-01-01 Rimassa, L; Personeni, N; Simonelli, M; Santoro, A
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
2018-01-01 Personeni, N; Pressiani, T; Santoro, A; Rimassa, L
SYSTEMIC TREATMENT OF HCC IN SPECIAL POPULATIONS
2021-01-01 Rimassa, Lorenza; Personeni, Nicola; Czauderna, Carolin; Foerster, Friedrich; Galle, Peter
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
2018-01-01 Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
2020-01-01 Pinato, David J; Kaseb, Ahmed; Wang, Yinghong; Saeed, Anwaar; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Khan, Uqba; Lee, Chiehju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Fessas, Petros; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Pressiani, Tiziana; Abugabal, Yehia I; Personeni, Nicola; Huang, Yi-Hsiang; Lozano-Kuehne, Jingky; Rimassa, Lorenza; Ang, Celina; Marron, Thomas U
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?
2007-01-01 Personeni, N.
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
2021-01-01 Jun, Tomi; Ozbek, Umut; Dharmapuri, Sirish; Hardy-Abeloos, Camille; Zhu, Huili; Lin, Jung-Yi; Personeni, Nicola; Pressiani, Tiziana; Nishida, Naoshi; Lee, Pei-Chang; Lee, Chieh-Ju; Hildebrand, Hannah; Nimkar, Neil; Paul, Sonal; Fessas, Petros; Naeem, Muntaha; Bettinger, Dominik; Khan, Uqba; Saeed, Anwaar; Huang, Yi-Hsiang; Kudo, Masatoshi; Rimassa, Lorenza; Marron, Thomas U; Pinato, David J; Ang, Celina
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib
2016-01-01 Rimassa, L; Abbadessa, G; Personeni, N; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, Be; Santoro, A
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases
2018-01-01 Viganò, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma
2021-01-01 Fessas, Petros; Naeem, Muntaha; Pinter, Matthias; Marron, Thomas U.; Szafron, David; Balcar, Lorenz; Saeed, Anwaar; Jun, Tomi; Dharmapuri, Sirish; Gampa, Anuhya; Wang, Yinghong; Khan, Uqba; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Pei-Chang; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I.; Pressiani, Tiziana; Personeni, Nicola; Nishida, Naoshi; Kudo, Masatoshi; Kaseb, Ahmed; Huang, Yi-Hsiang; Ang, Celina; Pillai, Anjana; Rimassa, Lorenza; Naqash, Abdul Rafeh; Sharon, Elad; Cortellini, Alessio; Pinato, David J.
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma
2015-01-01 Lopci, E; Torzilli, G; Poretti, D; De Neto, Ljs; Donadon, M; Rimassa, L; Lanza, E; Sabongi, Jg; Ceriani, R; Personeni, N; Palmisano, A; Pedicini, V; Comito, T; Scorsetti, M; Chiti, A
Role of liver biopsy in hepatocellular carcinoma
2019-01-01 Di Tommaso, L; Spadaccini, M; Donadon, M; Personeni, N; Elamin, A; Aghemo, A; Lleo A,
Role of liver biopsy in hepatocellular carcinoma
2019-01-01 Di Tommaso, L; Spadaccini, M; Donadon, M; Personeni, N; Elamin, A; Aghemo, A; Lleo, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Regorafenib for the treatment of unresectable hepatocellular carcinoma | 1-gen-2017 | Rimassa, L; Pressiani, T; Personeni, N; Santoro, A | |
| Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications | 1-gen-2016 | Personeni, N.; Baretti, M.; Bozzarelli, S.; Spaggiari, P.; Rubino, L.; Tronconi, M. C.; Fumagalli Romario, U.; Rosati, R.; Giordano, L.; Roncalli, M.; Santoro, A.; Rimassa, L. | |
| FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study | 1-gen-2015 | Personeni, N.; Rimassa, L.; Verusio, C.; Barni, S.; Rubino, L.; Bozzarelli, S.; Villa, E.; Carnaghi, C.; Tronconi, M. C.; Gerardi, C.; Galli, F.; Floriani, I.; Destro, A.; Raschioni, C.; Labianca, R.; Santoro, A. | |
| Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? | 1-gen-2018 | Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L | |
| Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer | 1-gen-2007 | M, Colozza; E, Azambuja; Personeni, N.; F, Lebrun; Mj, Piccart; F., Cardoso | |
| OncoAlert round table discussions: The global COVID-19 experience | 1-gen-2021 | Morgan, G; De Azambuja, E; Punie, K; Ades, F; Heinrich, K; Personeni, N; Rahme, R; Ferrara, R; Pels, K; Garassino, M; von Bergwelt-Baildon, M; Lopes, G; Barlesi, F; Choueiri, Tk; Burris, H; Peters, S | |
| Regorafenib for the treatment of unresectable hepatocellular carcinoma | 1-gen-2017 | Rimassa, L; Pressiani, T; Personeni, N; Santoro, A | |
| Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma | 1-gen-2013 | Rimassa, L; Personeni, N; Simonelli, M; Santoro, A | |
| Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications | 1-gen-2018 | Personeni, N; Pressiani, T; Santoro, A; Rimassa, L | |
| SYSTEMIC TREATMENT OF HCC IN SPECIAL POPULATIONS | 1-gen-2021 | Rimassa, Lorenza; Personeni, Nicola; Czauderna, Carolin; Foerster, Friedrich; Galle, Peter | |
| Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study | 1-gen-2018 | Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A | |
| Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy | 1-gen-2020 | Pinato, David J; Kaseb, Ahmed; Wang, Yinghong; Saeed, Anwaar; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Khan, Uqba; Lee, Chiehju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Fessas, Petros; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Pressiani, Tiziana; Abugabal, Yehia I; Personeni, Nicola; Huang, Yi-Hsiang; Lozano-Kuehne, Jingky; Rimassa, Lorenza; Ang, Celina; Marron, Thomas U | |
| Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing? | 1-gen-2007 | Personeni, N. | |
| Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma | 1-gen-2021 | Jun, Tomi; Ozbek, Umut; Dharmapuri, Sirish; Hardy-Abeloos, Camille; Zhu, Huili; Lin, Jung-Yi; Personeni, Nicola; Pressiani, Tiziana; Nishida, Naoshi; Lee, Pei-Chang; Lee, Chieh-Ju; Hildebrand, Hannah; Nimkar, Neil; Paul, Sonal; Fessas, Petros; Naeem, Muntaha; Bettinger, Dominik; Khan, Uqba; Saeed, Anwaar; Huang, Yi-Hsiang; Kudo, Masatoshi; Rimassa, Lorenza; Marron, Thomas U; Pinato, David J; Ang, Celina | |
| Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib | 1-gen-2016 | Rimassa, L; Abbadessa, G; Personeni, N; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, Be; Santoro, A | |
| Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases | 1-gen-2018 | Viganò, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G | |
| Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma | 1-gen-2021 | Fessas, Petros; Naeem, Muntaha; Pinter, Matthias; Marron, Thomas U.; Szafron, David; Balcar, Lorenz; Saeed, Anwaar; Jun, Tomi; Dharmapuri, Sirish; Gampa, Anuhya; Wang, Yinghong; Khan, Uqba; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Pei-Chang; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I.; Pressiani, Tiziana; Personeni, Nicola; Nishida, Naoshi; Kudo, Masatoshi; Kaseb, Ahmed; Huang, Yi-Hsiang; Ang, Celina; Pillai, Anjana; Rimassa, Lorenza; Naqash, Abdul Rafeh; Sharon, Elad; Cortellini, Alessio; Pinato, David J. | |
| Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma | 1-gen-2015 | Lopci, E; Torzilli, G; Poretti, D; De Neto, Ljs; Donadon, M; Rimassa, L; Lanza, E; Sabongi, Jg; Ceriani, R; Personeni, N; Palmisano, A; Pedicini, V; Comito, T; Scorsetti, M; Chiti, A | |
| Role of liver biopsy in hepatocellular carcinoma | 1-gen-2019 | Di Tommaso, L; Spadaccini, M; Donadon, M; Personeni, N; Elamin, A; Aghemo, A; Lleo A, | |
| Role of liver biopsy in hepatocellular carcinoma | 1-gen-2019 | Di Tommaso, L; Spadaccini, M; Donadon, M; Personeni, N; Elamin, A; Aghemo, A; Lleo, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71908
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa64
- 2020 - 202616999
- 2010 - 201923026
- 2000 - 200918345
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI972
- Elsevier Ltd761
- Elsevier B.V.651
- MDPI AG497
- Elsevier391
- John Wiley and Sons Inc327
- Springer321
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...299
- Elsevier Inc.264
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS282
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...196
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS180
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2917
- Female1597
- Male1493
- Middle Aged904
- Adult898
- Aged760
- Animals652
- Italy592
- Medicine (all)464
- COVID-19459
Lingua
- eng43532
- ita9129
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58598
- reserved8052
- open3768
- partially open822
- restricted667
- embargoed2
- mixed1